U.S., March 5 -- ClinicalTrials.gov registry received information related to the study (NCT06855953) titled 'Vitamin K and Cognition in Coronary Heart Disease (NutriCog)' on Feb. 20.
Brief Summary: The purpose of this pilot study is to obtain a preliminary assessment of the effect of VK supplementation on cognitive performance and vascular function in adults with stable Coronary Heart Disease (CHD)
Study Start Date: March 17
Study Type: INTERVENTIONAL
Condition:
Coronary Heart Disease
Intervention:
DIETARY_SUPPLEMENT: Vitamin K
Participants receive 0.5 mg/day phylloquinone orally for 12 weeks
DIETARY_SUPPLEMENT: Placebo
Participants receive daily placebo for 12 weeks
Recruitment Status: NOT_YET_RECRUITING
Sponsor: Montreal Heart...